Christian Lienhardt

15.9k total citations · 1 hit paper
133 papers, 6.8k citations indexed

About

Christian Lienhardt is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Christian Lienhardt has authored 133 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Infectious Diseases, 72 papers in Epidemiology and 30 papers in Surgery. Recurrent topics in Christian Lienhardt's work include Tuberculosis Research and Epidemiology (109 papers), Pneumocystis jirovecii pneumonia detection and treatment (31 papers) and Mycobacterium research and diagnosis (29 papers). Christian Lienhardt is often cited by papers focused on Tuberculosis Research and Epidemiology (109 papers), Pneumocystis jirovecii pneumonia detection and treatment (31 papers) and Mycobacterium research and diagnosis (29 papers). Christian Lienhardt collaborates with scholars based in United Kingdom, Switzerland and France. Christian Lienhardt's co-authors include Katherine Fielding, Keith P. W. J. McAdam, Mario Raviǵlione, Kebba Manneh, Andrew Nunn, Andrew Vernon, Jackson Sillah, Helen McIlleron, Madhukar Pai and Boubacar Bah and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Christian Lienhardt

133 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.

2022 167 citations Mark S. Butler, Valeria Gigante et al. Oxford University Research Archive (ORA) (University of Oxford) profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christian Lienhardt United Kingdom	46	5.1k	3.6k	1.7k	896	789	133	6.8k
Soumya Swaminathan India	44	5.3k 1.0×	3.6k 1.0×	1.7k 1.0×	697 0.8×	490 0.6×	276	7.7k
Neel R. Gandhi United States	35	5.5k 1.1×	4.4k 1.2×	2.0k 1.2×	696 0.8×	293 0.4×	125	6.7k
Timothy R. Sterling United States	51	9.1k 1.8×	6.6k 1.8×	3.5k 2.1×	724 0.8×	612 0.8×	244	11.6k
Graham Cooke United Kingdom	47	4.1k 0.8×	4.4k 1.2×	758 0.5×	500 0.6×	548 0.7×	188	9.1k
Hansjakob Furrer Switzerland	64	9.2k 1.8×	5.6k 1.6×	929 0.6×	707 0.8×	529 0.7×	276	14.3k
Paul Nunn Switzerland	31	4.9k 1.0×	3.9k 1.1×	1.9k 1.1×	754 0.8×	281 0.4×	52	6.0k
William J. Burman United States	47	4.8k 0.9×	3.6k 1.0×	1.3k 0.8×	511 0.6×	308 0.4×	121	6.8k
Timothy D. McHugh United Kingdom	48	5.7k 1.1×	4.5k 1.3×	1.9k 1.2×	2.0k 2.3×	384 0.5×	234	9.0k
Moses Joloba Uganda	47	5.2k 1.0×	4.2k 1.2×	1.7k 1.0×	953 1.1×	608 0.8×	318	7.8k
Megan Murray United States	56	7.7k 1.5×	6.0k 1.7×	2.6k 1.6×	1.6k 1.8×	552 0.7×	215	12.3k

Countries citing papers authored by Christian Lienhardt

Since Specialization

Citations

This map shows the geographic impact of Christian Lienhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Lienhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Lienhardt more than expected).

Fields of papers citing papers by Christian Lienhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Lienhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Lienhardt. The network helps show where Christian Lienhardt may publish in the future.

Co-authorship network of co-authors of Christian Lienhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Lienhardt. A scholar is included among the top collaborators of Christian Lienhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Lienhardt. Christian Lienhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Campbell, Jonathon R., Olivia Oxlade, Juan F Vesga, et al.. (2022). Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness. PLoS Medicine. 19(6). e1004032–e1004032. 9 indexed citations

Bonnet, Maryline, et al.. (2022). Perspectives d’élimination de la tuberculose : la stratégie OMS à l’épreuve de la pandémie de COVID-19. SPIRE - Sciences Po Institutional REpository. 1(2). 62–68. 1 indexed citations

Butler, Mark S., Valeria Gigante, Hatim Sati, et al.. (2022). Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed.. Oxford University Research Archive (ORA) (University of Oxford). 167 indexed citations breakdown →

Roelens, M., Giovanni Battista Migliori, Janne Estill, et al.. (2021). Evidence-based Definition for Extensively Drug-Resistant Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 204(6). 713–722. 16 indexed citations

Lienhardt, Christian, Andrew Nunn, Richard E. Chaisson, et al.. (2020). Advances in clinical trial design: Weaving tomorrow’s TB treatments. PLoS Medicine. 17(2). e1003059–e1003059. 14 indexed citations

Phillips, Patrick, Carole D. Mitnick, James D. Neaton, et al.. (2019). Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape. PLoS Medicine. 16(3). e1002767–e1002767. 15 indexed citations

Lienhardt, Christian, et al.. (2019). Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance. PLoS Medicine. 16(9). e1002915–e1002915. 11 indexed citations

Kik, Sandra V., Samuel G. Schumacher, Daniela María Cirillo, et al.. (2018). An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease. European Respiratory Journal. 52(4). 1800946–1800946. 21 indexed citations

Kendall, Emily A., Sourya Shrestha, Ted Cohen, et al.. (2017). Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model. PLoS Medicine. 14(1). e1002202–e1002202. 19 indexed citations

10.

Lan, Nguyễn Thị Ngọc, Nguyen Hong Duc, Nguyen Huy Dung, et al.. (2013). The ethics of a clinical trial when the protocol clashes with international guidelines [Unresolved issues]. Public Health Action. 3(2). 97–102. 1 indexed citations

11.

Lienhardt, Christian, et al.. (2012). The blueprint for vaccine research & development: Walking the path for better TB vaccines. Tuberculosis. 92. S33–S35. 7 indexed citations

12.

Luetkemeyer, Anne F., Haileyesus Getahun, Gabriel Chamie, Christian Lienhardt, & Diane V. Havlir. (2011). Tuberculosis Drug Development: Ensuring People Living with HIV Are Not Left Behind. American Journal of Respiratory and Critical Care Medicine. 184(10). 1107–1113. 16 indexed citations

13.

Menzies, Dick, Andrea Benedetti, Anita Paydar, et al.. (2009). Standardized Treatment of Active Tuberculosis in Patients with Previous Treatment and/or with Mono-resistance to Isoniazid: A Systematic Review and Meta-analysis. PLoS Medicine. 6(9). e1000150–e1000150. 145 indexed citations

14.

Cooke, Graham, Sarah J. Campbell, Steve Bennett, et al.. (2008). Mapping of a Novel Susceptibility Locus Suggests a Role for MC3R and CTSZ in Human Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 178(2). 203–207. 61 indexed citations

15.

Brookes, Roger H., Philip C. Hill, Patrick K. Owiafe, et al.. (2008). Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa. PLoS ONE. 3(8). e2921–e2921. 40 indexed citations

16.

Thiam, Sylla, et al.. (2007). Effectiveness of a Strategy to Improve Adherence to Tuberculosis Treatment in a Resource-Poor Setting. JAMA. 297(4). 380–380. 134 indexed citations

17.

Cooke, Graham, Sarah J. Campbell, Jackson Sillah, et al.. (2006). Polymorphism within the Interferon-γ/Receptor Complex is Associated with Pulmonary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 174(3). 339–343. 98 indexed citations

18.

Hill, Philip C., Dolly Jackson-Sillah, Simon Donkor, et al.. (2006). Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia. BMC Public Health. 6(1). 156–156. 78 indexed citations

19.

Sillah, Jainaba, Philip C. Hill, Richard A. Adegbola, et al.. (2003). Clinical and radiological presentation of 340 adults with smear-positive tuberculosis in The Gambia.. PubMed. 7(10). 942–7. 42 indexed citations

20.

Lienhardt, Christian, Katherine Fielding, Jackson Sillah, et al.. (2003). Risk Factors for Tuberculosis Infection in Sub-Saharan Africa. American Journal of Respiratory and Critical Care Medicine. 168(4). 448–455. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact